Search for: "Schering Corp" Results 121 - 140 of 251
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 May 2007, 8:57 am
Schering-Plough Corp., No. 05-273 (Jun. 26, 2006; denying certiorari), as well as three other recent petitions. [read post]
27 Jun 2007, 10:46 am
Schering-Plough Corp., No. 05-273 (Jun. 26, 2006; denying certiorari). [read post]
18 Mar 2013, 4:23 am by Dennis Crouch
Cir. 1981) ("The license waives this right to judicial relief against what, but for the license, would be an infringement."); Schering Corp. v. [read post]
8 Dec 2010, 10:42 am by FDABlog HPM
Geneva Pharms., Inc., 344 F.3d 1294, 1303 (11th Cir. 2003) and in Schering-Plough Corp. v. [read post]
21 Sep 2010, 7:47 pm by Kelly
(FDA Law Blog) US: FDA set to announce public hearing on BPCI Act implementation (FDA Law Blog) US: Precision Biosciences granted stay pending reexam of Cellectis’ patents (Patent Docs) US: Celsis granted preliminary injunction against CellzDirect in LiverPool hepatocyte treatment infringement suit (Patent Docs) US: Yeda Research and Development files suit against Abbott in District of Columbia requesting review of BPAI decision (Patent Docs) Products Angiomax (Bivalirudin) – US: The… [read post]
16 Oct 2006, 7:58 pm
Schering-Plough sued over a dozen companies who filed ANDA's to market generic versions of Clarinex. [read post]
16 Aug 2009, 9:21 pm
Whitehouse Station, New Jersey-based Merck, which is buying rival Schering-Plough Corp., had a reserve of about $42 million for the litigation, including lawyers' fees, it said. [read post]
21 Jun 2012, 10:00 pm by Stephanie Figueroa
District Court for the District of New Jersey's ruling against Merck on the issue of patent infringement in its suit against Apotex Inc. and Apotex Corp. [read post]
2 Apr 2020, 8:54 am by Jason Rantanen
Professor Sarnoff advances his premise through several arguments, drawing from the Federal Circuit’s precedent in Schering Corp. v. [read post]
16 Aug 2009, 2:20 am
" Schering-Plough Corp.'s Marvelon and Cerazette pills, which contain desogestrel, generated $319 million for the Kenilworth, New Jersey-based company in the first quarter, IMS Health data show. [read post]
21 Jun 2012, 10:00 pm by Stephanie Figueroa
District Court for the District of New Jersey's ruling against Merck on the issue of patent infringement in its suit against Apotex Inc. and Apotex Corp. [read post]